Innova Biosciences

What Innova Biosciences does

Innova Biosciences is a privately held life science tools company headquartered in Cambridge, United Kingdom, founded in 2002 and operating with a small (11-50 employee) team. Per the firmographic record, the company develops antibody labeling and bioconjugation kits, serving academic and pharmaceutical life science researchers who need ready-to-use conjugated antibodies and assay reagents for immunological, cellular biology, and disease research workflows.

The technology footprint documented in the inputs spans immunological reagents and assay technologies including antibodies, ELISA kits, and cellular assay kits. Documented proprietary feature elements include SimpleStep Ignite chemiluminescent ELISA technology (claiming 50x greater sensitivity and up to 35x broader measuring range than conventional ELISA, with 55-minute single-wash protocols), a knock-out validated recombinant antibody portfolio (4,900+ antibodies), a flow-validated metabolic enzyme antibody set covering 90% of key metabolic enzymes for immunometabolism research, and MollAI, an AI-powered product recommendation tool integrated into the catalog buying flow. Note that several of these capabilities are widely associated with a larger antibody reagent platform (Abcam) in external knowledge, and the input data does not explicitly establish or disambiguate any corporate relationship; treat technology attribution to Innova Biosciences specifically with caution.

The business model is a direct, catalog-driven e-commerce motion with global delivery to research institutions, offering both trial-size formats (e.g., 20 µL) and standard SKUs. Pricing is not publicly disclosed and no enterprise contract or subscription signals are documented. Go-to-market relies on content-driven demand generation (protocols, interactive pathways, product recommendation guides) and earned credibility via industry citations and awards rather than verticalized enterprise sales, addressing a horizontal base of life science researchers across academia and biopharma.

Name

Innova Biosciences

Website

https://innovabiosciences.com

Company type

Private

Founded year

2002

Headcount range

11–50 employees

Short description

Innova Biosciences is a privately held Cambridge, UK-based life science tools company (founded 2002, 11-50 employees) that develops antibody labeling and bioconjugation kits alongside immunological reagents, ELISA kits, and cellular assay products for academic and pharmaceutical researchers.

Ownership category

akta.pro rank

Product category

Research Antibodies and Assay Kits

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

Keywords

• Antibody labeling kits
• Bioconjugation reagents
• ELISA assay kits
• Recombinant antibodies
• Life science reagents

Headquarters

HQ city

Cambridge

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels4 records

Core offering

Innova Biosciences develops antibody labeling and bioconjugation kits for life science research. The company manufactures immunological reagents and assay technologies including recombinant antibodies, ELISA kits, and cellular assay kits used by academic and pharmaceutical researchers for protein detection across applications including IHC, ICC/IF, Western blot, flow cytometry, and ELISA.

Differentiator

Problem solved

Functional benefit

Products and services

• Antibody Labeling and Bioconjugation Kits The company's foundational product line of antibody labeling and bioconjugation kits used by academic and pharmaceutical researchers for protein detection and immunological research.
• SimpleStep Ignite Chemiluminescent ELISA Kits Chemiluminescent ELISA kits offering 50x greater sensitivity and up to 35x broader measuring range compared to conventional ELISA, with 55-minute single-wash assay completion across 1,000+ targets for life science researchers.
• Primary Antibodies Portfolio (Recombinant) Portfolio of 37,000+ recombinant antibodies including 4,900+ knock-out validated antibodies, available in conjugated and conjugation-ready formats, for academic and pharmaceutical research applications.
• Anti-PRAME Antibody [EPR20330] (ab219650) Rabbit recombinant monoclonal antibody used to detect PRAME in flow cytometry (intracellular), ICC/IF, IHC-P, IP, and Western blot applications.
• Human IL-6 ELISA Kit, Chemiluminescent (ab325448) 55-minute single-wash chemiluminescent SimpleStep ELISA kit designed for the rapid quantification of Human IL-6 with higher sensitivity for research applications.
• DCFDA / H2DCFDA Cellular ROS Assay Kit (ab113851) Complete kit for simplifying and accelerating the measurement of reactive oxygen species (ROS) in cell cultures for cellular biology researchers.
• Anti-GFP Antibody (ab290) Rabbit polyclonal antibody that detects all Aequorea victoria GFP variants, including RFP, YFP, CFP, and EGFP, across multiple applications, cited in over 3,360 publications.
• Gene-Edited Cell Lines High-quality, extensively validated gene-edited cell lines for life science research applications.
• Immunometabolism Flow Antibody Portfolio Portfolio of flow-validated antibodies covering 90% of key metabolic enzymes, designed drop-in ready for rapid expansion of immunometabolism flow cytometry panels.
• Spatial Biology Antibody Portfolio IHC-validated antibody portfolio covering spatial biology research workflows, tested and trusted by spatial biology experts.
• Alzheimer's Disease Imaging Antibody Portfolio Antibody portfolio covering 95% of core Alzheimer's disease genes, validated for imaging applications with human samples for Alzheimer's disease research.
• Trial-Size Antibody Catalog (20 µL) Trial-size antibody offering with 4,200+ antibodies available in 20 µL format (subset of 6,200+ recombinant antibodies in trial sizes), allowing researchers to validate antibody performance before committing to full-size purchase.

Quantifiable outcome

• 50x greater sensitivity compared to conventional ELISA methods
• +3 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators7 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Vector Laboratories: Developer of labeling and detection reagents, including antibody conjugates and biotin/streptavidin chemistries. Comparable in product category and customer base to Innova's bioconjugation offerings.
• Jackson ImmunoResearch: Specialist in antibody labeling, conjugation, and secondary reagents for research and diagnostics. Closest direct peer to Innova in conjugation chemistry and labeled antibody products.
• Abcam: Largest antibody reagent supplier globally, including conjugation kits and labeled antibodies. Innova Biosciences operates in an overlapping product space and the provided data includes extensive Abcam-specific content, suggesting a corporate relationship.
• Lumiprobe: Focused on fluorescent dyes and bioconjugation reagents for life science research. Comparable chemistry-first reagent business serving similar academic and pharma researchers.

Emerging players

• GenScript: CRO and reagent provider offering custom antibody services, conjugation, and recombinant protein production. Overlaps with Innova in custom bioconjugation and recombinant reagent services.
• Click Chemistry Tools: Specialist supplier of click chemistry and bioconjugation reagents for research and diagnostics. Comparable niche chemistry-first reagent business serving similar research customers.

Broad incumbents

• Bio-Rad Laboratories: Broad life-sciences tools provider with an antibody and reagent portfolio. Comparable as a broader incumbent in the same research reagent category as Innova.
• Cell Signaling Technology: Major antibody and reagent supplier for life-science research with a broad catalog including conjugated antibodies. Larger and broader than Innova but overlaps on antibody labeling and validation.
• Thermo Fisher Scientific: Global life-sciences tools incumbent offering antibodies, conjugation reagents, and labeling kits through brands such as Invitrogen and Thermo Scientific. Overlaps with Innova across product category at much greater scale.
• Merck KGaA (MilliporeSigma): Operates the Sigma-Aldrich and MilliporeSigma reagent brands, including extensive conjugation chemistry and antibody labeling products. Direct overlap with Innova but at vastly greater scale and distribution.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/InnovaBioSci
• Facebookfacebook.com/InnovaBiosciences

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innova Biosciences